GlassScriptPhysician profile
Andrew S Poole
NPI 1568874022
$30,371.71
in general payments reported to CMS, 2019-2025
21 companies · $3,376 in 2025
The $3,376 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,036 · 2020: $2,434 · 2021: $4,365 · 2022: $5,319 · 2023: $2,315 · 2024: $11K · 2025: $3,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,518 · Travel and Lodging: $5,636 · Food and Beverage: $4,016 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,518.47 |
| Travel and Lodging | $5,635.83 |
| Food and Beverage | $4,016.43 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $12,909.93 | 2019-2025 | Mako, Makoplasty, Tritanium |
| Smith+Nephew, INC. | $7,831.97 | 2019-2024 | Or3o Dual Mobility, Ri Hip Navigation, Journey |
| Medical Device Business Services, INC. | $7,119.43 | 2024 | |
| Zimmer Biomet Holdings, INC. | $998.40 | 2025 | Oxford |
| Depuy Synthes Sales INC. | $678.69 | 2020-2024 | Attune, Actis |
| Medacta USA, INC. | $140.38 | 2024 | |
| Orthalign INC | $136.67 | 2021 | |
| Radius Health, INC. | $108.88 | 2025 | Tymlos |
| Wright Medical Technology, INC. | $93.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $84.35 | 2022-2023 | Euflexxa |
| Onkos Surgical, INC. | $42.55 | 2022 | |
| Medtronic, INC. | $41.33 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $37.96 | 2025 | |
| Amgen INC. | $28.13 | 2023 | Evenity, Prolia |
| Horizon Therapeutics Plc | $26.26 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $26.11 | 2025 | |
| Heron Therapeutics, INC. | $13.90 | 2024 | Zynrelef |
| Bioventus LLC | $13.85 | 2022 | |
| Sanara Medtech INC. | $13.70 | 2023 | Celleraterx |
| Boston Scientific Corporation | $12.83 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Poole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.